Bluejay Diagnostics (BJDX) Total Liabilities (2020 - 2026)

Bluejay Diagnostics' Total Liabilities history runs 7 years deep, the most recent figure standing at $1.4 million for Q1 2026.

• In Q1 2026, Total Liabilities changed 0.41% year-over-year to $1.4 million; the TTM figure through Mar 2026 stood at $1.4 million (changed 0.41% YoY), while the FY2025 annual figure was $1.1 million, up 23.28% from the prior year.
• Total Liabilities came in at $1.4 million for Q1 2026 at Bluejay Diagnostics, up from $1.1 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $3.0 million in Q3 2023 to a low of $927924.0 in Q4 2024.
• A 5-year average of $1.6 million and a median of $1.6 million in 2022 frame the typical range for Total Liabilities.
• On a YoY basis, Total Liabilities climbed as much as 1241.6% in 2022 and fell as far as 62.95% in 2022.
• Bluejay Diagnostics' Total Liabilities stood at $2.0 million in 2022, then slipped by 0.32% to $2.0 million in 2023, then sank by 52.99% to $927924.0 in 2024, then climbed by 23.28% to $1.1 million in 2025, then rose by 23.9% to $1.4 million in 2026.
• According to Business Quant data, Total Liabilities over the past three periods registered $1.4 million, $1.1 million, and $1.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison